Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicOTCMKTS:MPSYY
Date8/2013
Raised
Post IPO Valuation

General Information

Offices

Germany
Lena-Christ-Strasse 48
82152 Martinsried/Planegg
DEU

People

Chief Executive Officer
Chairman & Supervisory Board
Chief Financial Officer
Member & Supervisory Board
Chief Development Officer
Chief Scientific Officer
Deputy Chairman & Supervisory Board
Member & Supervisory Board
Show All People

Acquisitions

Funding

TOTAL $126M
FUNDING TOTAL $126M
Private Equity, 9/2013
$126M

Tags

MorphoSys

MorphoSys AG, located in Martinsried/Munich, is one of the world’s leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Boehringer Ingelheim, Daiichi Sankyo, Merck & Co, Novartis, Pfizer, and Roche.

Recent Milestones

Videos

Screenshots

MorphoSys screenshot
Above: MorphoSys
Uploaded: 10/19/10

Stock Price

Sources

  1. MorphoSys Buys Sloning For $26.4M, Gains Synthetic Bio Technology (fis.dowjones.com) [edit]
  2. MorphoSys grabs $126M for clinical trial work (fiercebiotech.com) [edit]
  3. MorphoSys AG to Bank Potential $818 Million in Celgene Corporation (CELG) Deal for MOR202 (biospace.com) [edit]
Edit This Page
Last Edited 3/29/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy